2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine

C28H54N8O10 — CID 160588875

IUPAC2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine
SMILESCN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](CC(=O)[C@@H](O)CCN=C(N)N)C[C@H](N)C(O[C@H]3OC(CNCC(N)CO)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O
InChIInChI=1S/C28H54N8O10/c1-28(42)12-43-26(21(41)24(28)34-2)45-22-13(8-19(39)18(38)5-6-36-27(32)33)7-17(31)23(20(22)40)46-25-16(30)4-3-15(44-25)10-35-9-14(29)11-37/h3,13-14,16-18,20-26,34-35,37-38,40-42H,4-12,29-31H2,1-2H3,(H4,32,33,36)/t13-,14?,16+,17-,18-,20+,21+,22-,23?,24+,25+,26+,28-/m0/s1
InChIKeyKBMXJCLXEPBWQI-KYBBYHEXSA-N
MW662.79 g/mol
LogP-5.63
Rot. Bonds16

About 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine

2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine (PubChem CID 160588875) has the molecular formula C28H54N8O10 and a molecular weight of 662.79 g/mol. Its IUPAC name is 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine.

Molecular Properties

Compound Name2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine
PubChem CID160588875
Molecular FormulaC28H54N8O10
Molecular Weight662.79 g/mol
Exact Mass662.40
IUPAC Name2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine
SMILESCN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](CC(=O)[C@@H](O)CCN=C(N)N)C[C@H](N)C(O[C@H]3OC(CNCC(N)CO)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O
InChIInChI=1S/C28H54N8O10/c1-28(42)12-43-26(21(41)24(28)34-2)45-22-13(8-19(39)18(38)5-6-36-27(32)33)7-17(31)23(20(22)40)46-25-16(30)4-3-15(44-25)10-35-9-14(29)11-37/h3,13-14,16-18,20-26,34-35,37-38,40-42H,4-12,29-31H2,1-2H3,(H4,32,33,36)/t13-,14?,16+,17-,18-,20+,21+,22-,23?,24+,25+,26+,28-/m0/s1
InChIKeyKBMXJCLXEPBWQI-KYBBYHEXSA-N
XLogP-5.63
TPSA321.66 Ų
H-Bond Donors12
H-Bond Acceptors16
Rotatable Bonds16
Heavy Atoms46
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500662.79
LogP ≤ 5-5.63
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine?
The IUPAC name of 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine (CID 160588875) is 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine.
What is the SMILES notation for 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine?
The canonical SMILES for 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine is CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](CC(=O)[C@@H](O)CCN=C(N)N)C[C@H](N)C(O[C@H]3OC(CNCC(N)CO)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O.
What is the InChIKey of 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine?
The InChIKey is KBMXJCLXEPBWQI-KYBBYHEXSA-N. The full InChI is InChI=1S/C28H54N8O10/c1-28(42)12-43-26(21(41)24(28)34-2)45-22-13(8-19(39)18(38)5-6-36-27(32)33)7-17(31)23(20(22)40)46-25-16(30)4-3-15(44-25)10-35-9-14(29)11-37/h3,13-14,16-18,20-26,34-35,37-38,40-42H,4-12,29-31H2,1-2H3,(H4,32,33,36)/t13-,14?,16+,17-,18-,20+,21+,22-,23?,24+,25+,26+,28-/m0/s1.
What are the key properties of 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine?
2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine has a molecular weight of 662.79 g/mol, XLogP of -5.63, 16 rotatable bonds, 12 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3S)-5-[(1S,2S,3R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[[(2-amino-3-hydroxypropyl)amino]methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-3-hydroxy-4-oxopentyl]guanidine is sourced from PubChem (CID 160588875), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).